'Pharma Bro' Martin Shkreli Sees $10 Trillion Potential In Palantir, But Cautions: 'One Bad Quarter And It's Down 50%'

Why did Wells Fargo's asset cap get lifted? How are Trump's steel tariffs affecting the economy? What impact does Meta's nuclear deal have on AI? Why is Elon Musk criticizing Trump's spending bill? How did crowdstrike's earnings miss affect its stock? What caused Tesla's UK car sales to drop? Why is China's mineral export ban alarming automakers?

'Pharma Bro' Martin Shkreli Sees $10 Trillion Potential In Palantir, But Cautions: 'One Bad Quarter And It's Down 50%'

benzinga.com/analyst-stock-ratings/analyst-color/25/06/45716400/pharma-bro-martin-shkreli-sees-10-trillion-potential-in-palantir-but-cautions

Former hedge fund manager Martin Shkreli expressed bullish views on Palantir Technologies Inc. (NASDAQ:PLTR) while cautioning investors about the stock’s inherent volatility during an interview with popular PLTR investor Amit Kukreja.
What Happened: Shkreli, popularly known as "Pharma…

This story appeared on benzinga.com, 2025-06-02 09:31:02.